MiR-223 promotes cardiomyocyte apoptosis by inhibiting Foxo3a expression

P-P Wang1, Y-J Zhang, T Xie

  • 1Department of Nursing, Medical College, Hebei University of Engineering, Handan, Hebei, China.wangpeipei19@126.com.

Abstract

Insights

MicroRNA-223 (miR-223) promotes apoptosis in cardiomyocytes during oxidative stress. Inhibiting the miR-223/Foxo3a pathway may offer a therapeutic approach for cardiac injuries.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cellular Stress Response

Background:

  • MicroRNAs (miRs) play critical roles in cardiovascular disease pathogenesis.
  • Oxidative stress is a key factor in cardiomyocyte apoptosis and cardiac dysfunction.

Purpose of the Study:

  • To investigate the role of miR-223 in oxidative stress-induced apoptosis in cardiomyocytes.
  • To elucidate the underlying molecular mechanism involving the miR-223/Foxo3a axis.

Main Methods:

  • Construction of a mouse model of myocardial infarction (MI).
  • Primary cardiomyocyte culture subjected to hydrogen peroxide (H2O2) treatment.
  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR), cell viability assays, luciferase assays, Western blotting, and flow cytometry were utilized.

Main Results:

  • miR-223 expression was significantly upregulated in infarcted heart tissues and H2O2-treated cardiomyocytes.
  • miR-223 overexpression promoted apoptosis, while inhibition protected against oxidative stress-induced cell death.
  • miR-223 directly targets Foxo3a mRNA, inhibiting its protein expression. Silencing Foxo3a mimicked miR-223 effects.

Conclusions:

  • miR-223 acts as a significant regulator of cardiomyocyte apoptosis under oxidative stress conditions.
  • Targeting the miR-223/Foxo3a signaling pathway presents a potential therapeutic strategy for managing cardiac injuries.

Related Concept Videos

The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

4.0K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
15.1K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.2K
What is Gene Expression?01:42

What is Gene Expression?

Overview
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
196.8K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.5K